Tech Company Financing Transactions
Valora Therapeutics Funding Round
Avalon BioVentures, Alexandria Venture Investments and Bregua participated in a $30 million Seed capital raise for Valora Therapeutics. This VC investment round closed on 11/20/2024.
Transaction Overview
Company Name
Announced On
11/20/2024
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to advance its proprietary AbLec platform to develop novel immunotherapeutics.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
11099 N Torrey Pines Rd, Avalon BioVentures Accelerator 290
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Valora Therapeutics was born from a vision to translate groundbreaking glycobiology research into life-changing therapies. Founded in 2023, we build upon the pioneering work of Nobel Laureate Dr. Carolyn Bertozzi (Stanford University, HHMI investigator), a world leader in glycobiology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Miguel Garcia-Guzman
Browse more venture capital transactions:
Prev: 11/20/2024: Monkey Tilt venture capital transaction
Next: 11/20/2024: Aquaria venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs